Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT04907253
PHASE2
Quercetin in Coronary Artery By-pass Surgery
Sponsor: Montreal Heart Institute
View on ClinicalTrials.gov
Summary
The purpose of this study is to test the anti-inflammatory and anti-senescence effects of quercetin during coronary artery by-pass graft surgery.
Official title: Étude randomisée contrôlée Par Placebo de Phase II Visant à Mesurer l'Effet Anti-inflammatoire et Anti-sénescence de la quercétine Lors d'Une Chirurgie Cardiaque
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2021-06-04
Completion Date
2025-09-01
Last Updated
2025-05-08
Healthy Volunteers
No
Conditions
Interventions
DRUG
Quercetin
500 mg twice daily
DRUG
Placebo
twice daily
Locations (1)
Montreal Heart Institute
Montreal, Quebec, Canada